Results for weight-loss drug targeting amylin find similar efficacy across different doses and high rates of side effects, ...

Researchers at the University of Southern California found the popularity of nicotine pouches is soaring, especially among teenagers.

If phase 3 trial results are confirmed, a novel once-weekly pill platform could transform daily medications into weekly ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

Xifyrm is indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics.

Nicotine pouch maker a step closer to doing so after FDA moves forward modified risk tobacco product applications ...